Daewoong Pharmaceutical Co., Ltd (KRX:069620)
100,100
-600 (-0.60%)
Nov 17, 2026, 3:30 PM KST
| Market Cap | 1.15T -42.4% |
| Revenue (ttm) | 1.64T +9.9% |
| Net Income | 195.47B +160.3% |
| EPS | 16,988.64 +160.3% |
| Shares Out | 11.51M |
| PE Ratio | 5.89 |
| Forward PE | 6.52 |
| Dividend | 600.00 (0.60%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 20,144 |
| Open | 101,600 |
| Previous Close | 100,700 |
| Day's Range | 99,900 - 103,800 |
| 52-Week Range | 98,400 - 199,400 |
| Beta | 0.02 |
| Analysts | Buy |
| Price Target | 188,000.00 (+87.81%) |
| Est. Earnings | Feb 5, 2027 |
